Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized, Placebo-controlled Multi-center Trial to Compare the Phosphate Lowering Efficacy of Different Doses of SBR759 to Placebo

NCT01069692 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT01069692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01069692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized, Placebo-controlled Multi-center Trial to Compare the Phosphate Lowering Efficacy of Different Doses of SBR759 to Placebo
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2010
Completion date
Not reported
Enrollment
115 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, hyperphosphatemia